Cargando…
Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis
The prolyl-tRNA synthetase (PRS) is a validated drug target for febrifugine and its synthetic analog halofuginone (HFG) against multiple apicomplexan parasites including Plasmodium falciparum and Toxoplasma gondii. Here, a novel ATP-mimetic centered on 1-(pyridin-4-yl) pyrrolidin-2-one (PPL) scaffol...
Autores principales: | Yogavel, Manickam, Bougdour, Alexandre, Mishra, Siddhartha, Malhotra, Nipun, Chhibber-Goel, Jyoti, Bellini, Valeria, Harlos, Karl, Laleu, Benoît, Hakimi, Mohamed-Ali, Sharma, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974123/ https://www.ncbi.nlm.nih.gov/pubmed/36854028 http://dx.doi.org/10.1371/journal.ppat.1011124 |
Ejemplares similares
-
Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development
por: Manickam, Yogavel, et al.
Publicado: (2022) -
Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines
por: Sharma, Manmohan, et al.
Publicado: (2021) -
Aminoacyl tRNA synthetases as potential drug targets of the Panthera pathogen Babesia
por: Chhibber-Goel, Jyoti, et al.
Publicado: (2019) -
Drug targeting of aminoacyl-tRNA synthetases in Anopheles species and Aedes aegypti that cause malaria and dengue
por: Chakraborti, Soumyananda, et al.
Publicado: (2021) -
Engagement Rules That Underpin DBL-DARC Interactions for Ingress of Plasmodium knowlesi and Plasmodium vivax Into Human Erythrocytes
por: Yogavel, Manickam, et al.
Publicado: (2018)